Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: May 9, 2024
Date Accepted: Sep 20, 2024

The final, peer-reviewed published version of this preprint can be found here:

Interest in the Use of Herbal Supplements to Close the Treatment Gap for Hazardous Alcohol Use Among Men Who Have Sex With Men: Secondary Analysis of a Cross-Sectional Study

Hernandez C, Rowe C, Ikeda J, Arenander J, Santos GM

Interest in the Use of Herbal Supplements to Close the Treatment Gap for Hazardous Alcohol Use Among Men Who Have Sex With Men: Secondary Analysis of a Cross-Sectional Study

JMIR Form Res 2024;8:e60370

DOI: 10.2196/60370

PMID: 39471379

PMCID: 11558208

Can herbal supplements be employed to close the treatment gap for hazardous alcohol use? Interest in alternatives among Men who have Sex with Men.

  • Christopher Hernandez; 
  • Christopher Rowe; 
  • Janet Ikeda; 
  • Justine Arenander; 
  • Glenn-Milo Santos

ABSTRACT

Background:

Hazardous alcohol consumption is highly prevalent for men who have sex with men (MSM). The current 4 FDA-approved treatments for alcohol use are reaching an alarmingly low percentage of people who would benefit from a reduction in their alcohol use. There is increasing interest in alternative methods of treatment, such as herbal supplements, to address hazardous drinking. However, research on the acceptability of alternative pharmacotherapies among MSM remains limited.

Objective:

We examined the prevalence and correlates of expressing interest in using herbal supplements for alcohol treatment among MSM with hazardous alcohol consumption.

Methods:

We used data from a cross-sectional study of alcohol-using MSM conducted from March 2015 to July 2017 in San Francisco, CA, to assess the overall prevalence of interest in using herbal supplements to help reduce alcohol consumption. Associations between expressing interest in herbal supplements and demographic, social, and clinical characteristics were examined using bivariate and multivariable logistic regression

Results:

One-third (33%) of 200 participants expressed interest in an herbal supplement for reducing alcohol consumption. In the multivariable analyses, weekly binge drinking (aOR = 2.85; 95% CI = 1.17 - 6.93), interest in abstaining from alcohol use (aOR = 5.04; 95% CI = 1.46 - 17.40), higher severity of alcohol dependence score (aOR = 1.22; 95% CI = 1.04 - 1.41), and interest in naltrexone (aOR = 3.22; 95% CI = 2.12 - 4.91) were independently associated with higher odds of being interested in using an herbal supplement to reduce alcohol consumption, adjusting for age, race/ethnicity, and education.

Conclusions:

We found that MSM who have hazardous drinking habits, more severe alcohol dependence, and interest in pharmacotherapy were more likely to express interest in using an herbal supplement for reducing alcohol consumption. To our knowledge, this is the first study that has evaluated correlates of interest in herbal supplements for alcohol use among MSM. As researchers implement novel alcohol treatment studies, they should focus on recruitment efforts among MSM with a motivation to reduce their alcohol use patterns.


 Citation

Please cite as:

Hernandez C, Rowe C, Ikeda J, Arenander J, Santos GM

Interest in the Use of Herbal Supplements to Close the Treatment Gap for Hazardous Alcohol Use Among Men Who Have Sex With Men: Secondary Analysis of a Cross-Sectional Study

JMIR Form Res 2024;8:e60370

DOI: 10.2196/60370

PMID: 39471379

PMCID: 11558208

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.